GSK's Omjjara (momelotinib) approved in Singapore as the first treatment indicated for myelofibrosis patients with anaemia
GSK Singapore today announced that Omjjara (momelotinib) has been locally approved for treatment of disease-related ...
pharmaphorum1d
AbbVie invests $223m in Singapore biologics site
GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical manufacturing ...
pharmaphorum2d
FDA set to decide on GSK's gepotidacin antibiotic in March
according to GSK. At the same time, antimicrobial resistance (AMR) to common drugs used to treat these infections is on the rise, leading to treatment failure, with a Singapore study published ...
ETF Daily News2d
JPMorgan Chase & Co. Reaffirms “Underweight” Rating for GSK (LON:GSK)
GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a report issued on Friday, Marketbeat Ratings reports.